Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older.
Vila-Corcoles
Angel
A
Primary Care Service of Tarragona-Valls, Institut Catalá de la Salut, Tarragona, Spain.
Ochoa-Gondar
Olga
O
Guzmán
Jorge A
JA
Rodriguez-Blanco
Teresa
T
Salsench
Elisabet
E
Fuentes
Cruz M
CM
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D006801:Humans; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000276:immunology*
C414006:23-valent pneumococcal capsular polysaccharide vaccine; D022242:Pneumococcal Vaccines